Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-30 | Inhibrx, Inc. | Shabet Rose Sharon
(AtLeastTenPercentOwner) |
J | Common Stock | D | 7150826 | $30.00 - $30.00 | $214,524,780 |
| 2024-05-30 | Inhibrx, Inc. | Lappe Mark
(Chief Executive Officer) |
D | Common Stock | D | 3045654 | $30.00 - $30.00 | $91,369,620 |
| 2024-05-30 | Inhibrx, Inc. | Kayyem Jon Faiz
(Director) |
D | Common Stock | D | 3274301 | $30.00 - $30.00 | $98,229,030 |
| 2024-05-30 | Inhibrx, Inc. | FORSYTH DOUGLAS
(Director) |
D | Common Stock | D | 598257 | $30.00 - $30.00 | $17,947,710 |
| 2024-05-28 | Inhibrx, Inc. | Eckelman Brendan P.
(Chief Scientific Officer) |
S | Common Stock | D | 300000 | $34.30 - $34.30 | $10,290,000 |
| 2024-05-30 | Inhibrx, Inc. | Eckelman Brendan P.
(Chief Scientific Officer) |
D | Common Stock | D | 2055553 | $30.00 - $30.00 | $61,666,590 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |